Poseida Therapeutics Free Cash Flow (Quarterly) Trends

Poseida Therapeutics Inc (PSTX)

3.19 -0.16 (-4.63%) USD | NASDAQ | May 17, 16:00

3.19 0.00 (0.00%) After-Hours: 16:51

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
March 31, 2024	-15.26M
December 31, 2023	-29.05M
September 30, 2023	7.099M
June 30, 2023	-34.49M
March 31, 2023	-38.79M
December 31, 2022	2.143M
September 30, 2022	60.18M
June 30, 2022	-40.95M
March 31, 2022	-52.07M
December 31, 2021	8.26M
September 30, 2021	-41.24M

Date	Value
June 30, 2021	-32.67M
March 31, 2021	-39.53M
December 31, 2020	-32.47M
September 30, 2020	-32.13M
June 30, 2020	-39.24M
March 31, 2020	-26.40M
December 31, 2019	-17.95M
September 30, 2019	-20.99M
June 30, 2019	-15.81M
March 31, 2019	-14.93M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-52.07M

Minimum

Mar 2022

60.18M

Maximum

Sep 2022

-21.57M

Average

-30.59M

Median

Free Cash Flow (Quarterly) Benchmarks